SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

SPDR Gold Shares ETF ($GLD) is trending as gold prices reach new highs, driven by trade tensions and expectations of future rate cuts. The community is actively discussing whether this rally is sustainable or if a significant correction is on the horizon, with some seeing bubble-like conditions. Some traders point to potential factors that could either continue to fuel the run or trigger a pullback.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is experiencing volatility, with community members debating potential support levels and future price movements. News headlines regarding tariffs and potential geopolitical impacts are being discussed as possible catalysts. Some traders are expressing concerns about a potential market pullback and comparing Bitcoin's performance to gold.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as the community debates the stock's valuation and potential catalysts, including Trump's involvement and the company's Bitcoin holdings. Discussions also involve the broader implications of tariffs and government spending. Concerns about dilution and the company's financial performance are prominent talking points.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors discuss the potential impact of China's tightening battery export rules, which could favor the company's U.S.-based solid-state technology; the community is actively debating the stock's recent price action, with some seeing it as a buying opportunity while others express concerns about a possible pullback, also earnings are upcoming with investors hoping to see revenue.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue is trending due to legal challenges in the UK concerning talc-related cancer claims, sparking a sell-off despite the company's denial of the allegations. Community discussions revolve around the potential liability for Kenvue versus J&J, the extent of the overreaction, and whether this presents a buying opportunity given the company's dividend and well-known brands. Some traders are looking at short-term call options, while others are considering longer-term positions based on value and potential bounce-back.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as traders assess potential downside risk amid geopolitical tensions and anticipation of an upcoming announcement. Community members are weighing the possibility of a sharp reversal against concerns of deeper losses, with focus on key support levels. Discussions also involve broader market factors like bank performance and potential impacts from a former president's comments.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as traders discuss potential market volatility amid ongoing economic uncertainty and geopolitical tensions, including concerns about the government shutdown and trade relations. Community members are actively trading UVIX, anticipating a possible spike related to these factors, while also acknowledging the risks associated with holding this leveraged ETF due to its inherent decay. The conversation highlights a mix of short-term trading strategies and longer-term hedging approaches within the context of a market perceived by some as overvalued.

Aptera Motors Corp - Ordinary Shares - Class B

Aptera Motors Corp

Aptera Motors ($SEV) is trending following its direct listing on the Nasdaq, marked by significant volatility and trading halts. The community is actively discussing the stock's dramatic price movement, potential short-selling opportunities, and concerns about its financial stability post-listing. Some investors are also comparing it to other EV companies and past SPAC deals.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.

Tonix Pharmaceuticals Holding Corp

TNXP is trending due to discussions around its stock performance and commercial launch expectations for Tonmya. Community sentiment appears mixed, with some expressing frustration over the stock's recent decline and management's actions, while others remain optimistic about its long-term potential. The approved drug and potential pipeline advancements are overshadowed by concerns about dilution and the company's communication strategy.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending amid ongoing discussions about its AI strategy and infrastructure, particularly surrounding ambitious revenue projections and partnerships with companies like OpenAI. Community members are actively debating the sustainability of Oracle's growth, the validity of its AI-related claims, and its competitive positioning against other major cloud providers. Additionally, IBM's launch of new AI agents on the Oracle AI Agent Marketplace is generating buzz.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Sol-Gel Technologies (SLGL) were in the spotlight on Friday morning after the company’s first-quarter (Q1) revenue dipped below Wall Street expectations, and losses came in wider-than-expected.The company, which is focused on developing drugs for skin diseases, <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.sol-gel.com/news-releases/news-release-details/sol-gel-reports-first-quarter-2025-results">reported</a> total revenue of $1 million in the quarter, compared to $0.5 million for the same period in 2024, but below an analyst estimate of $1.2 million, as per FinChat data.Diluted loss per share came in at $3.2, compared to a loss of $2.3 per share for the same period in 2024, and exceeding an estimated loss of $1.2.The company’s research and development expenses soared in the three months through the end of March by 65% year-on-year to $8.8 million.Sol-Gel ended the quarter with $16.9 million in cash, cash equivalents, and deposits. The company expects the cash resources to fund its requirements into the first quarter of 2027.Sol-Gel has two FDA-approved drugs—TWYNEO for treating acne vulgaris in adults and pediatric patients nine years of age and older, and EPSOLAY for treating inflammatory lesions of rosacea in adults.The company is testing a drug candidate for the prevention of new basal cell carcinomas in Gorlin syndrome patients, and another for the treatment of rare skin keratodermas.Earlier this month, Sol-Gel announced a reverse share split at the ratio of 10-for-1 to increase its share price and regain compliance with requirements for continued listing on the exchange.On Stocktwits, retail sentiment around Sol-Gel stayed unchanged within the ‘bearish’ territory over the past 24 hours, coupled with ‘extremely low’ message volume.<figure class="image"><img style="aspect-ratio:624/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_23_at_9_39_02_AM_png_3d341c467c.webp" alt="SLGL's Sentiment Meter and Message Volume as of 9:40 a.m. ET on May 23, 2025 | Source: Stocktwits" width="624" height="63"><figcaption>SLGL's Sentiment Meter and Message Volume as of 9:40 a.m. ET on May 23, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/SLGL">SLGL stock</a> is down by about 25% this year and 5% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/trump-coin-gala-dinner-tells-crypto-backers-biden-made-your-lives-miserable/ch0QkElRbqY">Trump Coin Gala Dinner Highlights: US President Tells Crypto Backers Biden ‘Made Your Lives Miserable,’ Promises Relief</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

Sol-Gel Stock Tumbles Over Underwhelming Q1 Earnings: Retail Stays Pessimistic

The company’s diluted loss per share came in at $3.2, exceeding an estimated loss of $1.2.

Equity

The company’s diluted loss per share came in at $3.2, exceeding an estimated loss of $1.2.


Sol-Gel Technologies Announces Key Shareholder Decisions

Sol-Gel Technologies (SLGL) has released an update. Shareholders of Sol-Gel Technologies Ltd., a company based in Ness Ziona, Israel, have recently...

Sol-Gel Announces Executive Changes Amid Growth

Sol-Gel Technologies (SLGL) has released an update. Sol-Gel Technologies, a dermatology company known for its innovative skin treatments and FDA-ap...

Sol-Gel Technologies Announces Leadership Changes

Sol-Gel Technologies (SLGL) has released an update. Sol-Gel Technologies Ltd., an innovative dermatology company, announced a management realignmen...

Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve  Cream

Patent challenge initiated by Arcutis BiotherapeuticsNESS ZIONA, Israel, April 01, 2024 (GLOBE NEWSWIRE) -- Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company pioneering treatments...

Sol-Gel Technologies collaboration partner first-to-file ANDA generic to Zoryve

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Sol-Gel Technologies: Q4 Earnings Insights

Sol-Gel Technologies reports 2023 EPS ($1.01) vs. (65c) last year

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

An ongoing phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened; Results are expected by the end of 2025 Sol-Gel maintains a cash runway into the second half of 2025...

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Ltd

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

SLGL
Sol-Gel Technologies Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SLGL News

SLGLSol-Gel Technologies Ltd